Sign In
Get Clay Free →

Suggestions

    Ruairi O'Donnell

    EU HTA lead - Cencora

    Ruairi O'Donnell, PhD, is currently the EU HTA Lead at Cencora, a role he assumed recently as part of the company's strategic focus on European market access and health technology assessment (HTA). With over 20 years of experience in global market access and health economics and outcomes research (HEOR), O'Donnell has held various leadership positions in prominent consulting firms prior to his tenure at Cencora. His expertise encompasses value strategy, evidence development, and navigating market access pathways.

    In his current position, O'Donnell is tasked with guiding clients through the complexities introduced by the new EU HTA Regulation, which will take effect in January 2025. He aims to provide strategic and technical support to manufacturers in the life sciences industry, ensuring they can effectively navigate the evolving landscape of health technology assessments in Europe. His work involves understanding local healthcare systems and engaging with stakeholders to optimize access to innovative therapies.12

    Highlights

    Navigating new access hurdles in Europe - AmerisourceBergen
    Navigating new access hurdles in Europe - AmerisourceBergen

    Related Questions

    What are Ruairi O'Donnell's key achievements in his 20-year career?
    How does Ruairi O'Donnell plan to navigate the new EU HTA challenges?
    What specific strategies does Ruairi O'Donnell recommend for manufacturers facing EU HTA hurdles?
    How does Ruairi O'Donnell's background in value strategy benefit Cencora's clients?
    What are the main goals Ruairi O'Donnell has set for his role at Cencora?